News

IEEE CoG 2026: Industry Day and Game Dev Tutorials Recap

general · 5 min

FDA Places Clinical Hold on Newron's Evenamide Phase III Trial for Treatment-Resistant Schizophrenia

Treatment-Resistant Schizophrenia (TRS) · 3 min

Teva Reports Strong Q1 2026 Results as PONLIMSI Biosimilar Receives FDA Approval and Olanzapine LAI Advances

2 min

Teva Acquires Emalex Biosciences for First-in-Class Tourette Syndrome Drug Ecopipam

2 min

Teva's PONLIMSI Biosimilar Receives FDA Approval for All Prolia Indications as Q1 2026 Results Show Strong Growth

2 min

Bayer Presents 13 Stroke Research Abstracts at ESOC 2026, Including Asundexian Phase III Trial Data

2 min

Tempest Therapeutics TPST-2003 CAR-T Shows Promise for Multiple Myeloma at ISCT 2026

2 min

Pfizer's ELREXFIO Shows Significant Progression-Free Survival Improvement in Multiple Myeloma Phase 3 Trial

Oncology - Multiple Myeloma · 3 min

Rein Therapeutics LTI-03 Phase 2 Trial Enrolls 8 Patients for Idiopathic Pulmonary Fibrosis Treatment

3 min

Laguna Biotherapeutics Receives FDA Clearance for LGNA-100 Pediatric Leukemia Trial

FDA · 2 min

Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Hemophilia A Stem Cell Therapy

FDA · 2 min

FDA Grants Priority Review for Gilead's Bictegravir Plus Lenacapavir HIV Treatment Combination

FDA · HIV Treatment · 3 min